Caleres, Inc. Common Stock (NY:CAL)

12.10 -0.08 (-0.70%)

Delayed Quote Updated: 11:07 AM EDT, Oct 1, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Caleres, Inc. Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Caleres Names Jack Calandra As Finance Chief ↗

August 29, 2022

Via Benzinga

Jack Calandra Named Senior Vice President, Chief Financial Officer of Caleres

August 29, 2022

From Caleres

Via Business Wire

Sam Edelman Debuts its Fall/Winter 2022 Campaign, Featuring Supermodel Naomi Campbell

August 29, 2022

From Caleres

Via Business Wire

Caleres Declares Regular Quarterly Dividend

August 25, 2022

From Caleres

Via Business Wire

Lululemon Athletica Stock Sees Improved Relative Price Strength ↗

August 25, 2022

On Thursday, Lululemon Athletica stock had its Relative Strength Rating upgraded to 71 from 67 a day earlier.

Via Investor's Business Daily

Short Volatility Alert: Caleres, Inc. ↗

May 31, 2022

On Friday, shares of Caleres, Inc. (NYSE: CAL) experienced volatile short activity. After the activity, the stock price went up +7.51% to $29.63. The overall sentiment for CAL has...

Via Benzinga

Caleres Q1 Earnings Beat Street View, Raises FY22 Outlook ↗

May 25, 2022

Via Benzinga

Why Minerva Neurosciences Shares Traded Higher By Over 66%; Here Are 78 Biggest Movers From Yesterday ↗

August 25, 2022

Gainers Minerva Neurosciences, Inc. (NASDAQ: NERV) shares gained 66.5% to close at $7.51 after Point72 Asset Management reported an 8.8% passive stake in the company.

Via Benzinga

Advance Auto Parts, Nordstrom And Other Big Stocks Recording Losses On Wednesday ↗

August 25, 2022

U.S. stocks closed higher with the Nasdaq Composite gaining 50 points on Wednesday. Here is the list of some big stocks moving lower in the previous session.

Via Benzinga

12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session ↗

August 24, 2022

Via Benzinga

Caleres Reports Record Consolidated Net Sales and Earnings in Second Quarter 2022 and Reiterates Full Year 2022 Earnings Per Share Guidance

August 23, 2022

From Caleres

Via Business Wire

Why Citi Trends Is Trading Lower By 17%, Here Are 47 Stocks Moving In Wednesday's Mid-Day Session ↗

August 24, 2022

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 77% to $2.35. Bright Minds priced overnight marketed offering of 2.858 million units at $1.40 per unit.

Via Benzinga

Earnings Scheduled For August 23, 2022 ↗

August 23, 2022

Companies Reporting Before The Bell • Regis (NYSE:RGS) is estimated to report earnings for its fourth quarter. • Jianpu Technology (NYSE:JT) is likely to report earnings for its second quarter.

Via Benzinga

A Preview Of Caleres's Earnings ↗

August 22, 2022

Caleres (NYSE:CAL) is set to give its latest quarterly earnings report on Tuesday, 2022-08-23. Here's what investors need to know before the announcement. Analysts estimate that Caleres will report an...

Via Benzinga

Caleres to Announce Second Quarter 2022 Results on August 23

August 03, 2022

From Caleres

Via Business Wire

Caleres Announces Timeline for Planned Executive Succession

July 25, 2022

From Caleres

Via Business Wire

12 Consumer Discretionary Stocks Moving In Monday's After-Market Session ↗

June 27, 2022

Gainers Tuesday Morning (NASDAQ:TUEM) shares moved upwards by 12.8% to $0.4 during Monday's after-market session. The market value of their outstanding shares is at $33.9 million.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 24, 2022 ↗

June 24, 2022

Upgrades

Via Benzinga

Top Mid-Cap Stocks: Trading Opportunities For Next Week - Sunday, June 19 ↗

June 19, 2022

A security pattern traces the distinct movements of security prices that, once recognized, help traders to make informed trading decisions. Let's look at some mid-cap stock opportunities by analyzing...

Via Talk Markets

Caleres's Ex-Dividend Date Is Thursday, Here's What You Need To Know ↗

June 06, 2022

Wednesday marks the last chance for investors to receive the next dividend payout from Caleres (NYSE:CAL).

Via Benzinga

Caleres Shares Support for LGBTQIA+ Associates and Customers

June 01, 2022

From Caleres

Via Business Wire

Caleres Declares Regular Quarterly Dividend

May 26, 2022

From Caleres

Via Business Wire

88 Biggest Movers From Yesterday ↗

May 26, 2022

Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) shares jumped 118.2% to close at $0.2950 on Wednesday as the company announced it increased retail distribution across Canada with Loblaw...

Via Benzinga

12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session ↗

May 25, 2022

Via Benzinga

Mid-Day Market Update: Gold Drops Over 1%; StoneMor Shares Jump ↗

May 25, 2022

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 80 points on Wednesday.

Via Benzinga

Mid-Morning Market Update: Markets Rise; Nasdaq Gains 100 Points ↗

May 25, 2022

U.S. stocks traded higher this morning, with the Nasdaq Composite gaining around 100 points on Wednesday.

Via Benzinga

12 Consumer Discretionary Stocks Moving In Wednesday's Pre-Market Session ↗

May 25, 2022

Via Benzinga

50 Stocks Moving In Wednesday's Mid-Day Session ↗

May 25, 2022

Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) gained 178.3% to $0.3762 as the company announced it increased retail distribution across Canada with Loblaw Companies.

Via Benzinga

11 Consumer Discretionary Stocks Moving In Tuesday's After-Market Session ↗

May 24, 2022

Gainers Wendy's (NASDAQ:WEN) shares increased by 16.6% to $18.97 during Tuesday's after-market session. Trading volume for this security closed at 277.2K, accounting for 10.1% of its average full-day...

Via Benzinga

Caleres Reports First Quarter 2022 Results

May 24, 2022

From Caleres

Via Business Wire

< Previous 1 2

...

9 10 11 12 13 14 15 16 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.